• BD EVP and President, Medical Essentials and Biopharma Michael David Garrison sold 1,100 common shares on June 24, 2026.
• Sale price USD 145.66 per share; holdings fell to 13,172 shares.
• Transaction executed under a Rule 10b5-1 trading plan adopted Feb. 18, 2026.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. BD - Becton, Dickinson and Company published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001628280-26-045374), on June 25, 2026, and is solely responsible for the information contained therein.